| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/27/1997 | CA2223814A1 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents |
| 02/26/1997 | EP0759468A1 Feline interleukin-4 |
| 02/26/1997 | EP0759437A1 Processes for the production of 2-isocephem derivatives |
| 02/26/1997 | EP0759301A2 Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759077A1 Lanthionine-containing antimicrobial compound |
| 02/26/1997 | EP0759072A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants |
| 02/26/1997 | EP0758899A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
| 02/26/1997 | EP0758893A1 Potentiated antibiotic composition |
| 02/26/1997 | EP0758892A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
| 02/26/1997 | EP0726911A4 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 02/26/1997 | EP0552267B1 Engineered bacteriophages and vaccines containing them |
| 02/26/1997 | EP0541753B1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT |
| 02/26/1997 | EP0519976B1 Neutrophil stimulating peptides |
| 02/26/1997 | CN1143978A Antimicrobial proteins from aralia and impatiens |
| 02/26/1997 | CN1143966A L-nucleosides for treatment of hepatitis B-virus and epstein-bar virus |
| 02/26/1997 | CN1143965A Carbocyclic compound |
| 02/26/1997 | CN1143954A Anilide derivatives as fungicides |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/26/1997 | CN1143496A Improving tolerability of pharmaceutically active beta-amino acids |
| 02/26/1997 | CN1143495A Ointment for eliminating tinea |
| 02/26/1997 | CN1034122C Process for preparing antiviral tetrahydroimioazo|1,4¨ benzodiazepin-2-(thi) ones |
| 02/25/1997 | US5606108 Process for preparing anionic polycarbonate and polyester oligomers having useful antiviral properties |
| 02/25/1997 | US5606030 Coconjugates of OMPC, HIV related peptides and anionic moieties |
| 02/25/1997 | US5606024 Canine G-CSF polypeptides and pharmaceutical compositions comprising same |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605926 Trifluoromethyl-containing pseudopeptides active against retroviruses |
| 02/25/1997 | US5605921 Triazole derivatives and salts thereof, and antifungal agent containing the same |
| 02/25/1997 | US5605919 Prevention of cell injury |
| 02/25/1997 | US5605910 Bactericides |
| 02/25/1997 | US5605895 Cephalosporin antibiotics and processes for preparation thereof |
| 02/25/1997 | US5605889 Contains a disintegrant and exhibits no adverse food effect |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | US5605689 Treatment of HIV-associated immune thrombocytopenic purpura |
| 02/25/1997 | US5605688 Recombinant dog and horse type I interferons |
| 02/25/1997 | CA2184046A1 Pharmaceutical compositions containing a neutralized virus and use thereof |
| 02/25/1997 | CA2127763C Alkaloids from mappia foetida, the use thereof and formulations containing them |
| 02/25/1997 | CA2078805C Cytokine preparation |
| 02/23/1997 | CA2183804A1 Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006253A1 Method of modulating gene expression with reduced immunostimulatory response |
| 02/20/1997 | WO1997006174A1 Isomerisation process |
| 02/20/1997 | WO1997006172A1 Novel penam sulfones as beta-lactamase inhibitors |
| 02/20/1997 | WO1997006160A1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor |
| 02/20/1997 | WO1997006157A1 Dihydropyran derivatives as viral neuraminidase inhibitors |
| 02/20/1997 | WO1997005878A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005877A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005873A2 Use of fluconazole for inhibiting the growth of cancers |
| 02/20/1997 | WO1997005870A2 Use of griseofulvin for inhibiting the growth of cancers |
| 02/20/1997 | WO1997005864A2 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs |
| 02/20/1997 | WO1997002821A3 Antifungal agent, compound therefor, process for producing the same |
| 02/20/1997 | WO1996040668A3 Small molecule inhibition of rna/ligand binding |
| 02/20/1997 | DE19530884A1 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Infektionen Use of prostane derivatives and their combination with antibiotics to treat bacterial infections |
| 02/20/1997 | CA2512366A1 Mammalian iap gene family, primers, probes and detection methods |
| 02/20/1997 | CA2229024A1 Use of fluconazole for inhibiting the growth of cancers |
| 02/20/1997 | CA2228528A1 Novel penam sulfones as beta-lactamase inhibitors |
| 02/20/1997 | CA2228513A1 Isomerisation process |
| 02/20/1997 | CA2228503A1 Use of griseofulvin for inhibiting the growth of cancers |
| 02/20/1997 | CA2228136A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2228050A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758681A2 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 02/19/1997 | EP0758396A1 Feline immunodeficiency virus vaccine |
| 02/19/1997 | EP0758339A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
| 02/19/1997 | EP0758327A1 Pyranone compounds useful to treat retroviral infections |
| 02/19/1997 | EP0758312A1 Substituted fused and bridged bicyclic compounds as therapeutic agents |
| 02/19/1997 | EP0758250A1 Texaphyrin solid-supports and devices |
| 02/19/1997 | EP0758245A1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori |
| 02/19/1997 | EP0758244A1 Controlled-release dosage forms of azithromycin |
| 02/19/1997 | EP0758240A1 Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections |
| 02/19/1997 | EP0758235A1 Polymer coated tablet comprising amoxycillin and clavulanate |
| 02/19/1997 | EP0491878B1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/19/1997 | CN1143373A 乙型肝炎疫苗 Hepatitis B Vaccine |
| 02/19/1997 | CN1143363A Isoxazoline compounds as inhibitors of TNF release |
| 02/19/1997 | CN1143080A Method for preparing 7-bicyclic substituted -3-quinone derivative |
| 02/19/1997 | CN1142895A Fungicidal compounds and its use |
| 02/19/1997 | CN1034074C Preparing method for heterocycle-substituted benzenemethanamine derivatives |
| 02/18/1997 | US5604262 Topical antimicrobial agents |
| 02/18/1997 | US5604258 Methods for treating malaria and other diseases |
| 02/18/1997 | US5604230 Useful in inhibiting the replication of hiv |
| 02/18/1997 | US5604217 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for their preparation |
| 02/18/1997 | US5604209 Combination of 6-benzyl-1-ethoxymethyl-5-isopropyluracil anddideoxyribonucleosides; treating human immunodeficiency virus |
| 02/18/1997 | US5604201 Methods and reagents for inhibiting furin endoprotease |
| 02/18/1997 | US5604117 Immunizing animal with specified peptide coupled to immunogenic carrier, preparing hybridoma producing monoclonal antibody, isolating antibody |
| 02/18/1997 | US5603938 High molecular weight surface proteins of non-typeable haemophilus |
| 02/17/1997 | CA2183469A1 New cephalosporins containing a substituted benzyloxyimino radical in position 7; process and intermediates for preparing them and use thereof as therapeutic agents |
| 02/15/1997 | CA2183049A1 Derivatives of 12, 13-epoxy-tylosin and processes of manufacture thereof |
| 02/13/1997 | WO1997005279A1 Methods of predicting the outcome of infection |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997005164A1 Papillomavirus polyprotein constructs |
| 02/13/1997 | WO1997005163A1 Cyclic peptide anti-fungal agents |
| 02/13/1997 | WO1997005142A1 Process for the preparation of potassium clavulanate |
| 02/13/1997 | WO1997005131A1 New carboxamides with antifungal activity |
| 02/13/1997 | WO1997005130A1 New pyrimidone derivatives with antifungal activity |
| 02/13/1997 | WO1997005113A1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases |
| 02/13/1997 | WO1997004791A1 Antiviral agent and process for preparing the same |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |